What Should You Do When the Title Is Misleading?

What if the title gives you the wrong impression of the study?

Titles are useful screening shortcuts, but they are not complete descriptions of research. A title may omit the population, emphasize only one outcome, use an unexpected name for an intervention, describe the topic broadly, or even suggest a study design that becomes less clear once you read the paper.

This creates a practical problem during literature screening. If the title looks irrelevant, should you exclude the record immediately? What if the study underneath that title actually satisfies your inclusion criteria?

The safest principle is simple: make eligibility decisions from the evidence available about the study, not from the title alone when the title leaves meaningful uncertainty.

Do not let the title overrule the study itself

A title is evidence about a paper, not the final eligibility decision

Why research titles can mislead screeners

A research title is necessarily compressed. Authors have limited space and may prioritize the intervention, phenomenon, headline finding, theoretical concept, or memorable framing rather than every characteristic a reviewer needs for eligibility screening.

Reporting guidance recognizes this problem indirectly by specifying information that good titles should communicate. CONSORT 2025, for example, recommends identifying a randomized trial as randomized in its title because explicit identification helps readers and bibliographic systems recognize the study design. Its explanation notes that inadequate identification can affect retrieval and indexing.

Empirical research also suggests that titles are not uniformly informative. One study of pediatric orthopedic publications classified titles as misleading when important study characteristics were omitted or discordant and found substantial problems with title reporting in its particular sample. That finding should not be generalized to all disciplines, but it illustrates why a title cannot always carry the full burden of an eligibility decision.

Misleading, incomplete, and simply unfamiliar are not the same thing

A third possibility is easy to overlook: the title may be accurate, but it uses terminology you did not anticipate. An intervention may have several names, a population may be described by a setting rather than a demographic label, or a discipline may use terminology unfamiliar to researchers working in another field.

That matters because "this title does not sound relevant" is not itself an exclusion criterion. Your task is to determine whether the record satisfies the criteria established for the review.

Title screening should favor sensitivity when information is uncertain

JBI guidance states that study selection should be based on eligibility criteria established earlier in the review process and describes selection at both title/abstract and full-text stages. Its guidance on title and abstract screening emphasizes making retrieval decisions with the review question and protocol criteria in mind.

This means a title can support exclusion when it provides enough information to establish that a criterion is definitely not met. If your review includes only human studies and a title unambiguously identifies an animal experiment, for example, the title may provide sufficient evidence for exclusion.

But when the title merely fails to establish eligibility, the situation is different. Absence of information is not necessarily evidence of ineligibility.

The abstract is the next source of evidence, not an infallible answer

When a title appears misleading or uninformative, read the abstract. Look specifically for the elements relevant to your eligibility criteria rather than merely asking whether the paper sounds interesting.

Depending on your review, you might check the population, intervention or exposure, comparator, outcome, setting, study design, or other prespecified characteristics. This is essentially the same disciplined process used when screening titles and abstracts against eligibility criteria.

The abstract, however, should not automatically be treated as ground truth. Research comparing abstracts with corresponding full reports has documented omissions and inconsistencies, particularly in biomedical literature. A scoping review of methodological studies concluded that abstracts can be inconsistent with their corresponding full reports. A later systematic review covering thousands of randomized trials and systematic reviews likewise found problems in abstract reporting and consistency with full texts.

CONSORT 2025 consequently states that an abstract should accurately reflect the full article and should not contain information absent from the body of the paper.

Retrieve the full text when the abstract cannot resolve eligibility

If the title and abstract together still leave a reasonable possibility that the study satisfies your criteria, move it forward rather than forcing a premature decision.

This is particularly important when the missing information concerns a decisive criterion. Perhaps the abstract says "university students" but does not specify whether they were undergraduates. Perhaps it reports a digital intervention without clarifying whether the intervention performed the function required by your review. Perhaps the outcome is described using a broader construct than your eligibility criteria permit.

In these situations, the question becomes whether the full text is needed to establish eligibility. Retrieving one extra paper costs some time. Incorrectly excluding an eligible study can alter the evidence base itself.

A misleading title is not a reason to change your criteria

Discovering that a paper is more relevant than its title suggests does not justify bending your inclusion criteria. Once you uncover what the study actually examined, apply the same criteria you would have applied to any other study.

If it qualifies, retain it. If it does not, exclude it for the applicable eligibility reason. "Misleading title" would rarely be the substantive reason for exclusion because the title's quality is normally not what determines whether the underlying study belongs in the review.

Do not confuse poor reporting with poor methodology

An unhelpful title can make a paper difficult to identify, but it does not establish that the underlying research is methodologically weak. Conversely, a precise and informative title does not establish that the study is rigorous.

This distinction is consistent with keeping eligibility screening separate from detailed methodological appraisal. The title helps you locate and initially classify evidence. Critical appraisal addresses a different question about the credibility and limitations of that evidence.

A paper that looks irrelevant until you read beyond the title

Common mistakes when a title does not tell the whole story

Escalate the evidence before escalating the certainty of your decision

Treat screening as a staged information problem. Use the title when it provides enough information. Move to the abstract when it does not. Retrieve the full text when the abstract still leaves an eligibility criterion unresolved.

If uncertainty persists even after full-text inspection, handle the record using a consistent procedure rather than making an improvised judgment. This becomes part of the broader problem of handling borderline studies without arbitrary decisions.

Before excluding a paper because of its title, check this

Questions about misleading titles during literature screening

Screen the study, not merely its headline

How to Cite This Guide

This guide is intended to be read, shared, and used in research, teaching, and academic work. If you draw on its ideas, explanations, or other content, please acknowledge the source by citing the guide. Doing so gives appropriate credit and helps your readers locate the original resource.